Malignant pheochromocytoma of the urinary bladder: Effectiveness of radiotherapy in conjunction with chemotherapy

International Journal of Urology

Volumn 11, Issue 3, 2004, Pages 175-177

  Yoshida, Soichiro ^a,b   Nakagomi, Kazuaki ^a   Goto, Shuichi ^a   Kobayashi, Satoshi ^a  

^a HAMAMATSU MEDICAL CENTER   (Japan)

^b NONE   (Japan)

Author keywords

Bladder; Chemotherapy; Malignant pheochromocytoma; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CATECHOLAMINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; BLADDER CANCER; CANCER INHIBITION; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE URINE LEVEL; HUMAN; JAPAN; LYMPH NODE METASTASIS; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 1942539035     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2003.00758.x     Document Type: Article

References (6)

1. Piedrola G, Lopez E, Rueda MD, Lopez R, Serrano J, Sancho M. Malignant pheochromocytoma of the bladder: Current controversies. Eur. Urol. 1997; 31: 122-5.
2. Thrasher JB, Humphrey PA, Rajan RR, Anderson EE, Perez LM. Pheochromocytoma of urinary bladder: contemporary methods of diagnosis and treatment options. Urology 1993; 41: 435-9.
3. Whalen RK, Althausen AF, Daniels GH. Extra-adrenal pheochromocytoma. J. Urol. 1992; 147: 1-10.
4. Averbuch SD, Steakley CS, Young RC et al. Malignant pheochromocytoma. Effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazinc. Ann. Intern. Med. 1988; 109: 267-73.
5. Schlumberger M, Gicquel C, Lumbroso J et al. Malignant pheochromocytoma: Clinical, biological, histlogic and therapeutic data in a series of 20 patients with distant metastases. J. Endocrinol. Invest. 1992; 15: 631-42.
6. Naguib M, Caceres M, Thomas CR, Herman TS, Eng TY. Radiation treatment of recurrent pheochromocytoma of the bladder. Am. J Clin. Oncol. 2002; 25: 42-4.